Zobrazeno 1 - 10
of 435
pro vyhledávání: '"David G Pfister"'
Autor:
Tony K W Hung, Gilad J Kuperman, Eric J Sherman, Alan L Ho, Chunhua Weng, David G Pfister, Jun J Mao
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e60695 (2024)
Externí odkaz:
https://doaj.org/article/4ee9c132db9943aa8e717d27fd60e408
Autor:
Siqing Fu, Rom S Leidner, Ki Chung, Jiaxin Niu, Ilian Tchakov, Debra L Richardson, Xiaoping Qing, Jorge Nieva, Douglas Adkins, Alan L Ho, Minh Phan, Alexander T Pearson, Marshall R Posner, Lisle Nabell, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Trisha Kaufmann, Christopher Plescia, Corinne Iacobucci, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2139506c3af64695acf470195ba8dd75
Autor:
Erin F. Gillespie, Noah J. Mathis, Max Vaynrub, Ernesto Santos Martin, Rupesh Kotecha, Joseph Panoff, Andrew L. Salner, Alyson F. McIntosh, Ranju Gupta, Amitabh Gulati, Divya Yerramilli, Amy J. Xu, Meredith Bartelstein, David M. Guttmann, Yoshiya J. Yamada, Diana Lin, Kaitlyn Lapen, Deborah Korenstein, David G. Pfister, Allison Lipitz-Snyderman, Jonathan T. Yang
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 35, Iss , Pp 76-83 (2022)
Purpose: Local treatment for bone metastases is becoming increasingly complex. National guidelines traditionally focus only on radiation therapy (RT), leaving a gap in clinical decision support resources available to clinicians. The objective of this
Externí odkaz:
https://doaj.org/article/2ed751d803634ef392e59226e6674df5
Autor:
Daniel Restifo, MA, Gabriel Raab, BA, Sean M. McBride, MD, MPH, David G. Pfister, MD, Richard J. Wong, MD, Nancy Y. Lee, MD, Armin Shahrokni, MD, MPH, Kaveh Zakeri, MD, MAS
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101096- (2023)
Purpose: Treatment patterns for head and neck squamous cell carcinoma (HNSCC) vary among older adults because of concerns about their health status. Geriatric assessment may guide treatment for older adults with HNSCC by assessing their health status
Externí odkaz:
https://doaj.org/article/672592fed3a24477a6a19fd9ae27b5d6
Autor:
Tony K.W. Hung, Shelly Latte-Naor, Yuelin Li, Gilad J. Kuperman, Christina Seluzicki, Eva Pendleton, David G. Pfister, Jun J. Mao
Publikováno v:
JCO Oncology Practice. 19:e185-e196
PURPOSE: Accelerated by the COVID-19 pandemic, the virtual platform has become a prominent medium to deliver mind-body therapies, but the extent to which patients engage in virtual mind-body programming remains unclear. This study aims to assess onco
Autor:
Nancy Y. Lee, Nadeem Riaz, Vanessa Wu, Thomas Brinkman, Chiaojung J. Tsai, Wanquing Zhi, James Fetten, Alan Ho, Richard J. Wong, Ronald Ghossein, Michael Tuttle, James Fagin, David G. Pfister, Eric Sherman
Publikováno v:
Thyroid
BACKGROUND: Metastatic anaplastic thyroid cancer (ATC) has a poor prognosis. This pilot study aims to evaluate tremelimumab plus durvalumab with stereotactic body radiotherapy (SBRT) to improve overall survival (OS). METHODS: Eligible patients receiv
Autor:
Vatche, Tchekmedyian, Lara, Dunn, Eric, Sherman, Shrujal S, Baxi, Ravinder K, Grewal, Steven M, Larson, Keith S, Pentlow, Sofia, Haque, R Michael, Tuttle, Mona M, Sabra, Stephanie, Fish, Laura, Boucai, Jamie, Walters, Ronald A, Ghossein, Venkatraman E, Seshan, Jeffrey A, Knauf, David G, Pfister, James A, Fagin, Alan L, Ho
Publikováno v:
Thyroid
BACKGROUND: Oncogenic activation of mitogen-activated protein kinase (MAPK) signaling is associated with radioiodine refractory (RAIR) thyroid cancer. Preclinical models suggest that activation of the receptor tyrosine kinase erbB-3 (HER3) mitigates
Autor:
Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S. Baxi, Ravinder K. Grewal, Steven M. Larson, Keith S. Pentlow, Sofia Haque, R. Michael Tuttle, Mona M. Sabra, Stephanie Fish, Laura Boucai, Jamie Walters, Ronald A. Ghossein, Venkatraman E. Seshan, Jeffrey A. Knauf, David G. Pfister, James A. Fagin, Alan L. Ho
Publikováno v:
Thyroid. 32:273-282
Autor:
Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Thomas Galloway, Jessica L. Geiger, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra Leizman, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, James W. Rocco, Cristina P. Rodriguez, Panayiotis S. Savvides, David Schwartz, Jatin P. Shah, David Sher, Maie St. John, Randal S. Weber, Gregory Weinstein, Frank Worden, Justine Yang Bruce, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan D. Darlow
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:224-234
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The s
Autor:
David G. Pfister, Robert I. Haddad, Francis P. Worden, Jared Weiss, Ranee Mehra, Laura Q. M. Chow, Stephen V. Liu, Hyunseok Kang, Nabil F. Saba, Lori J. Wirth, Ammar Sukari, Erminia Massarelli, Mark Ayers, Andrew Albright, Andrea L. Webber, Robin Mogg, Jared Lunceford, Lingkang Huang, Razvan Cristescu, Jonathan Cheng, Tanguy Y. Seiwert, Joshua M. Bauml
Publikováno v:
Cancer medicineREFERENCES.
We performed an integrated biomarker evaluation in pembrolizumab-treated patients with R/M HNSCC enrolled in KEYNOTE-012 or KEYNOTE-055. The relationship between biomarkers and HPV status was explored.We evaluated PD-L1 (combined positive score [CPS]